The negative enrichment method with CD45 antibodies to remove leukocytes and subsequent identification using a combination of ASGPR and CPS1 antibodies were conducted to identify CTCs from peripheral blood of HCC patients. This evidence concerns the gene CPS1 and hepatocellular carcinoma.